Faeth Therapeutics, Inc.
FTH· Nasdaq
Released Mar 28, 2025, before the open
10-K filed Mar 28, 2025, 87 days after period end · 0000950170-25-046338
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$7.77M | -$7.41M | -$12.23M | -$9.37M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Faeth Therapeutics, Inc. · CIK 1829802 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2024 · filed Mar 28, 2025 · 87 d after period end
+15.9% from the close of Mar 27, 2025 to the close of Mar 28, 2025, the first after the release.